C4 Therapeutics to Participate in Upcoming September Investor Conferences

Core Insights - C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on advancing targeted protein degradation science to develop innovative medicines [3] Group 1: Company Announcements - C4 Therapeutics management will participate in fireside chats at two investor conferences in September 2024 [1] - The first event is the Wells Fargo Healthcare Conference in Boston, MA on September 5, 2024, at 8:45 AM ET [2] - The second event is the 2024 Cantor Global Healthcare Conference in New York, NY on September 18, 2024, at 8:35 AM ET [2] Group 2: Company Overview - C4 Therapeutics is leveraging its TORPEDO® platform to design and optimize small-molecule medicines aimed at difficult-to-treat diseases [3] - The company's degrader medicines utilize the body's natural protein recycling system to degrade disease-causing proteins, potentially overcoming drug resistance and improving patient outcomes [3]